
Charles River Laboratories International
Research models, and outsourced preclinical services for the accelerated r&d of drugs.
Market cap
$7.4b
Enterprise value
$10.1b
Share price
$151.73 CRL
Authorizing premium user...
Research models, and outsourced preclinical services for the accelerated r&d of drugs.